BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

LifeScience Emerging Biotech

XtalPi Launches AI-Powered Kodexia Platform to Accelerate siRNA Drug Discovery

This unified platform integrates sequence design, chemical modification, experimental validation, extrahepatic delivery design, and intellectual property...

October 07, 2026 | News

EpiSign, Geneyx Partner to Integrate Genomic and Epigenomic Analysis for Rare Diseases

Collaboration brings EpiSign's comprehensive DNA methylation episignature analysis together with the Geneyx genomic and multi-omics analysis platform EpiS...

October 07, 2026 | News

Bambusa Doses First Patient in Subcutaneous Cohort of Phase I BBT001 Trial

First patient dosed as Bambusa expands global development of its long-acting bispecific antibody targeting both IL-4Rα and IL-31 High-concentration ...

October 05, 2026 | News

XtalPi-Backed Viva-Thera Advances AI-Designed HIV Candidate to Preclinical Stage in Seven Months

Viva-Thera makes its public debut with four modalities pursuing HIV prevention, treatment and cure, supported by XtalPi's platform capabilities. Viva-Th...

September 24, 2026 | News

CelluPro Becomes First Chinese Cell Culture Media Supplier to Secure EXCiPACT GMP Certification

CelluPro, a biotechnology company specializing in serum-free cell culture media and bioprocess solutions, has achieved EXCiPACT™ GMP Certif...

September 09, 2026 | News

Rznomics Advances High-Efficiency Circular RNA Production with Engineered STS Technology

Rznomics Inc.(KOSDAQ: 476830), a biopharmaceutical company specializing in the development of RNA-based gene therapies, announced a major breakthrough in t...

September 08, 2026 | News

AstraZeneca Secures US FDA Approval for ETCAMAH Combination in Advanced Breast Cancer

Approval based on SERENA-6 Phase III trial results which showed combination reduced the risk of disease progression or death by 56% in patients with an e...

September 08, 2026 | News

Novonesis Invests €600M to Expand Enzyme Production Facility in India

Novonesis will expand its facility in Patalganga and build one of the world's most advanced enzyme production facilities. The €600 million investment ...

September 07, 2026 | News

DualityBio, Genentech Ink $1B-Plus Deal to Develop Next-Generation ADCs Against Drug-Resistant Tumours

Collaboration leverages DualityBio's proprietary DUPAC payload platform and early global clinical development capabilities, with Genentech assuming furth...

August 31, 2026 | News

PENTAX Medical, MAGENTIQ EYE Expand AI-Assisted Colonoscopy Partnership Globally

Expanded agreement combines PENTAX Medical's continued investment in flexible reusable endoscopy with MAGENTIQ's clinically validated AI capabilities, expa...

August 28, 2026 | News

South Korea’s Rznomics Joins Lilly Gateway Labs in US to Accelerate RNA Gene Therapies

Rznomics Inc.(KOSDAQ: 476830), a biopharmaceutical company specializing in the development of RNA-based gene therapies, announced that it is joining Lilly ...

August 25, 2026 | News

Kyowa Kirin Taps Cognizant and Benchling to Build AI-Powered Drug Discovery Foundation in Japan

Cognizant announced that it will support the introduction and implementation of Benchling, the AI platform for R&D at Tokyo Research Park and Fuji Rese...

August 18, 2026 | News

IASO Bio Acquires Singapore’s MediSix Therapeutics to Strengthen Global Cell Therapy Platform

- IASO Biotechnology announced the completion of its acquisition of MediSix Therapeutics , a Singapore-based immune cell engineering and cell therapy compa...

August 17, 2026 | News

ArkBio’s Long-Acting Influenza Candidate AK0406 Secures IND Approval in China

Shanghai Ark Biopharmaceutical Co., Ltd. announced that the Investigational New Drug (IND) application for AK0406 injection, the company's first long-actin...

August 14, 2026 | News

Stay Connected